一个单独麻醉师的成本效益在通过导管的大动脉置换在患有严重并发症的患者中
Kimberly L Skidmore1, Alan D Kaye1, Kamian M Buggage1
1Department of Anesthesiology, School of Medicine, Louisiana State University Health Sciences Center, Shreveport, USA.
Cureus
|September 19, 2025
概括
识别需要全身麻醉 (GA) 而不是有意识镇静 (CS) 的患者进行跨导管大动脉置换 (TAVR) 是至关重要的. 多学科团队的早期风险评估可以防止高死亡率的新兴转换.
科学领域:
- 心脏病学 心脏病学
- 麻醉学 麻醉学
- 医疗器械 医疗器械
背景情况:
- 透导管大动脉置换 (TAVR) 通常使用大腿动脉方法,特别是在患有大动脉狭窄的老年患者中.
- 意识镇静 (CS) 越来越多地成为TAVR的标准,因为它有诸如更快的恢复和更低的成本等好处.
- 一般麻醉 (GA) 仅适用于有自发呼吸或心血管崩风险的患者.
研究的目的:
- 评估风险因素和转换TAVR患者从CS到GA的最佳时间.
- 确定需要监控麻醉护理 (MAC) 的患者子组,而不是CS.
- 为了为患有阻塞性睡眠呼吸暂停 (OSA) 和充血性心力衰竭 (CHF) 等并发症的患者制定分拣策略.
主要方法:
- 对TAVR患者数据的回顾性分析.
- 多学科团队会议,包括心脏麻醉科医生,以进行风险分层.
- 影响GA与CS或MAC决定因素的评估.
主要成果:
- 在TAVR期间突发转换为GA与显著的30%的死亡率有关.
- 积极识别风险因素对于适当的麻醉选择至关重要.
- 特定的患者个人资料需要仔细的麻醉规划,以避免不良事件.
结论:
- 每月与心脏麻醉医生的多学科会议对于TAVR患者风险评估至关重要.
- 识别需要MAC而不是CS的患者可以改善结果.
- 对于高风险的TAVR患者,建议对OSA和CHF采取早期干预策略,包括优化镇静和通风.
相关概念视频
Mitral Stenosis III: Medical Management
247
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
247
Aortic Regurgitation III: Medical Management
399
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
399


